106 related articles for article (PubMed ID: 27039632)
1. An Assessment of Performance Between Medicare Advantage and Stand-Alone Prescription Drug Plans on Two Quality Assurance Measures.
Blackwell SA; Shrank WH; Riley GF
J Med Pract Manage; 2016; 31(4):200-8. PubMed ID: 27039632
[TBL] [Abstract][Full Text] [Related]
2. How does drug treatment for diabetes compare between Medicare Advantage prescription drug plans (MAPDs) and stand-alone prescription drug plans (PDPs)?
Erten MZ; Stuart B; Davidoff AJ; Shoemaker JS; Bryant-Comstock L; Shenolikar R
Health Serv Res; 2013 Jun; 48(3):1057-75. PubMed ID: 23205568
[TBL] [Abstract][Full Text] [Related]
3. Rural-Urban Enrollment in Part D Prescription Drug Plans: June 2017 Update.
Weigel P; Ullrich F; Mueller K
Rural Policy Brief; 2017 Dec; 2017(7):1-6. PubMed ID: 29693334
[TBL] [Abstract][Full Text] [Related]
4. Socioeconomic characteristics of enrollees appear to influence performance scores for medicare part D contractors.
Young GJ; Rickles NM; Chou CH; Raver E
Health Aff (Millwood); 2014 Jan; 33(1):140-6. PubMed ID: 24395946
[TBL] [Abstract][Full Text] [Related]
5. An Assessment of Three Post-Discharge Drug-Based Quality Assurance Events for Elderly Medicare Beneficiaries Enrolled in a Stand-Alone Part D Plan.
Blackwell SA; Riley GF; Li J
J Med Pract Manage; 2016 Sep; 32(2):93-97. PubMed ID: 29944796
[TBL] [Abstract][Full Text] [Related]
6. Management of Medicare Part D Prescription Drug Plans and Medication Adherence: A Conceptual Framework and Empirical Analysis.
Young GJ; Rickles NM; Benzer JK; Dangi A
Med Care; 2017 Jan; 55(1):37-42. PubMed ID: 27547952
[TBL] [Abstract][Full Text] [Related]
7. Predictors of high-risk prescribing among elderly Medicare Advantage beneficiaries.
Cooper AL; Dore DD; Kazis LE; Mor V; Trivedi AN
Am J Manag Care; 2014 Oct; 20(10):e469-78. PubMed ID: 25414985
[TBL] [Abstract][Full Text] [Related]
8. Underreporting high-risk prescribing among Medicare Advantage plans: a cross-sectional analysis.
Cooper AL; Kazis LE; Dore DD; Mor V; Trivedi AN
Ann Intern Med; 2013 Oct; 159(7):456-62. PubMed ID: 24081286
[TBL] [Abstract][Full Text] [Related]
9. Medicare Advantage and Fee-for-Service Performance on Clinical Quality and Patient Experience Measures: Comparisons from Three Large States.
Timbie JW; Bogart A; Damberg CL; Elliott MN; Haas A; Gaillot SJ; Goldstein EH; Paddock SM
Health Serv Res; 2017 Dec; 52(6):2038-2060. PubMed ID: 29130269
[TBL] [Abstract][Full Text] [Related]
10. Psychometric evaluation of the Medicare Advantage and prescription drug plan disenrollment reasons survey.
Martino SC; Elliott MN; Zaslavsky AM; Orr N; Bogart A; Ye F; Damberg CL
Health Serv Res; 2019 Aug; 54(4):930-939. PubMed ID: 31025723
[TBL] [Abstract][Full Text] [Related]
11. Adverse selection in the Medicare prescription drug program.
Riley GF; Levy JM; Montgomery MA
Health Aff (Millwood); 2009; 28(6):1826-37. PubMed ID: 19887424
[TBL] [Abstract][Full Text] [Related]
12. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
Cline RR; Worley MM; Schondelmeyer SW; Schommer JC; Larson TA; Uden DL; Hadsall RS
Res Social Adm Pharm; 2010 Jun; 6(2):130-42. PubMed ID: 20511112
[TBL] [Abstract][Full Text] [Related]
13. Medication use and adherence among elderly Medicare beneficiaries with diabetes enrolled in Part D and retiree health plans.
Stuart B; Simoni-Wastila L; Yin X; Davidoff A; Zuckerman IH; Doshi J
Med Care; 2011 May; 49(5):511-5. PubMed ID: 21422956
[TBL] [Abstract][Full Text] [Related]
14. Do Restrictions on Antipsychotic Use Differ Between Medicare Part D Stand-Alone Versus Medicare Advantage Plans?
Chou J; Brandt NJ; Loh FE; Stuart B
Consult Pharm; 2017 Feb; 32(2):109-118. PubMed ID: 28569663
[TBL] [Abstract][Full Text] [Related]
15. Medicare program; policy and technical changes to the Medicare Advantage and the Medicare prescription drug benefit programs. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2010 Apr; 75(72):19677-826. PubMed ID: 20422785
[TBL] [Abstract][Full Text] [Related]
16. Adjusting Medicare Advantage star ratings for socioeconomic status and disability.
Sorbero ME; Paddock SM; Damberg CL; Haas A; Kommareddi M; Tolpadi A; Mathews M; Elliott MN
Am J Manag Care; 2018 Sep; 24(9):e285-e291. PubMed ID: 30222924
[TBL] [Abstract][Full Text] [Related]
17. Relationships between Medicare Advantage contract characteristics and quality-of-care ratings: an observational analysis of Medicare Advantage star ratings.
Xu P; Burgess JF; Cabral H; Soria-Saucedo R; Kazis LE
Ann Intern Med; 2015 Mar; 162(5):353-8. PubMed ID: 25732277
[TBL] [Abstract][Full Text] [Related]
18. Rural-Urban Differences in Satisfaction with Medicare Part D: Implications for Policy.
Henning-Smith C; O'Connor H; Casey M; Moscovice I
J Aging Soc Policy; 2016; 28(2):65-80. PubMed ID: 26808390
[TBL] [Abstract][Full Text] [Related]
19. Impact of Medicare Advantage Prescription Drug Plan Star Ratings on Enrollment before and after Implementation of Quality-Related Bonus Payments in 2012.
Li P; Doshi JA
PLoS One; 2016; 11(5):e0154357. PubMed ID: 27149092
[TBL] [Abstract][Full Text] [Related]
20. Variation in diabetes care quality among medicare advantage plans: understanding the role of case mix.
Abraham JM; Marmor S; Knutson D; Zeglin J; Virnig B
Am J Med Qual; 2012; 27(5):377-82. PubMed ID: 22205769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
